Search research articles
Contact Us
Filters
Showing results (301-310 of 420) with videos related to
Page
of 42
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 12, 2001
Quality control parameters for cefditoren susceptibility tests
P C Fuchs, A L Barry, S D Brown, et al.
Journal of Clinical Microbiology
|
November 1, 1986
Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria
A L Barry, J L Cotton, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
August 1, 1992
In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains
K E Aldridge, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1989
The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers
R N Jones, A L Barry, R V Gardiner, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1988
An in vitro evaluation of HRE 664, a novel penem antibiotic
P C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology
|
July 1, 1982
Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods
R N Jones, A L Barry, J Bigelow, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1985
Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability
A L Barry, R N Jones, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1991
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations
P C Fuchs, S Stickel, P H Anderson, et al.
Journal of Clinical Microbiology
|
December 1, 1979
Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test
A L Barry, M B Coyle, C Thornsberry, et al.
Journal of Clinical Microbiology
|
April 1, 1992
Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae
P C Fuchs, A L Barry, C Baker, et al.
Page
of 42
Search research articles
Search
Showing results (301-310 of 420) with videos related to
Sort By:
Page
of 42
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 12, 2001
Quality control parameters for cefditoren susceptibility tests
P C Fuchs, A L Barry, S D Brown, et al.
Journal of Clinical Microbiology
|
November 1, 1986
Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria
A L Barry, J L Cotton, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
August 1, 1992
In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains
K E Aldridge, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1989
The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers
R N Jones, A L Barry, R V Gardiner, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1988
An in vitro evaluation of HRE 664, a novel penem antibiotic
P C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology
|
July 1, 1982
Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods
R N Jones, A L Barry, J Bigelow, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1985
Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability
A L Barry, R N Jones, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1991
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations
P C Fuchs, S Stickel, P H Anderson, et al.
Journal of Clinical Microbiology
|
December 1, 1979
Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test
A L Barry, M B Coyle, C Thornsberry, et al.
Journal of Clinical Microbiology
|
April 1, 1992
Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae
P C Fuchs, A L Barry, C Baker, et al.
Page
of 42